<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="24640">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02785991</url>
  </required_header>
  <id_info>
    <org_study_id>RECABA</org_study_id>
    <nct_id>NCT02785991</nct_id>
  </id_info>
  <brief_title>Spanish Registry of Cryoballoon Ablation</brief_title>
  <acronym>RECABA</acronym>
  <official_title>Prospective Observational Study of Pulmonary Vein Cryoablation in Subjects With Atrial Fibrillation (AF) in Spain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic Bakken Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this registry is to reflect on standard clinical practice in pulmonary vein
      cryoablation in Spanish hospitals, the different procedure protocols, details of
      intervention, complications, long-term follow-up strategy and results in these subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      With this study the investigators propose the performance of a prospective registry of
      pulmonary vein cryoablation in subjects with paroxysmal or persistent AF at Spanish sites to
      estimate evaluate the efficacy of the cryoablation procedure at 12 months, defined as the
      absence of recurrences of atrial fibrillation.

      Secondary objectives are also defined as:

        -  Description of the profile of subjects who undergo this type of procedure (demographic
           factors, cardiovascular risk factors, medication, physical activity, sleep apnea,
           alcohol, smoking, chronic pulmonary disease, obesity, etc.).

        -  To evaluate the acute efficacy of the procedure: complete isolation of the pulmonary
           veins demonstrated by the successful electrical disconnection of the pulmonary veins in
           the cryoablation procedure.

        -  Description of the complications related to the procedure.

        -  To evaluate the use of healthcare resources which this cryoablation procedure entails.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The efficacy of the cryoablation procedure at 12 months, defined as the absence of recurrences of atrial fibrillation.</measure>
    <time_frame>12 months</time_frame>
    <description>Recurrence of AF will be defined as a clinically diagnosed episode of AF and accordingly documented (on ECG, Holter monitor with a duration of at least 30 seconds or implantable devices or event recording systems).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The acute efficacy of the procedure:</measure>
    <time_frame>24-48h</time_frame>
    <description>complete isolation of the pulmonary veins demonstrated by the successful electrical disconnection of the pulmonary veins in the cryoablation procedure.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Atrial Fibrillation</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Balloon cryoablation</intervention_name>
    <description>pulmonary vein cryoablation for atrial fibrillation</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The sample size will be approximately 1000 subjects who must be enrolled over the two-year
        period, based on the annual rate of cryoballoon ablations carried out in Spain.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signature of the Data Release Form

          -  Subjects ≥ 18 years old

          -  Subjects who meet the indication for the Cryoballoon Ablation procedure.

        Exclusion Criteria:

          -  Subjects with a life expectancy of less than 12 months.

          -  Subjects who meet the exclusion criteria defined by local legislation (e.g., age,
             pregnancy, breastfeeding, etc.).

          -  Subjects who may currently be enrolled, or who plan to take part, in a study with a
             drug or device that may cause bias during the course of this study.

          -  Co-participation in concurrent trials is only allowed when documented pre-approval is
             obtained from the Medtronic study manager.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Patricia Pascual</last_name>
    <phone>+34 636 18 38 69</phone>
    <email>patricia.pascual@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Roger Villuendas, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Puerta de Hierro</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorge Toquero, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jorge Toquero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Ermengol Vallés, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica ZorroTzaurre</name>
      <address>
        <city>Bilbao</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesús daniel Martínez Alday, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Basurto</name>
      <address>
        <city>Bilbao</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Jesús D Martínez Alday, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundación Jiménez Díaz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Manuel Rubio, MD</last_name>
    </contact>
    <investigator>
      <last_name>José Manuel Rubio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Rafael Peinado, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Arcadio Garcia Alberola, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rocío Cózar, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Ernesto Díaz Infante, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 20, 2016</lastchanged_date>
  <firstreceived_date>May 25, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>At the end of the study Publication for primary endpoint. Complementary analysis may be published, also at the end of the study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
